AM31: Dr. Charles Theuer, CEO & President of TRACON Pharmaceutical

Today, Rusty Shelton welcomes the CEO and President of TRACON Pharmaceuticals Dr. Charles Theuer on the show to talk about his entrepreneurial journey in the healthcare industry and how he and his team are contributing to the evolution of medical trials. Dr. Theuer also gives tips on how to disrupt the industry you are in.

About Charles Theuer:
Dr. Charles Theuer has been CEO and President and a Director of TRACON Pharmaceuticals since 2006. Dr. Theuer has been instrumental in bringing novel blockbuster oncology drugs to market, including Sutent® to treat advanced kidney cancer, while working as Director of Clinical Oncology at Pfizer. Dr. Theuer has held senior management positions at notable biotechnology firms, including TargeGen, Inc., and IDEC Pharmaceutical Corp. He has worked at the National Cancer Institute and held academic positions at the University of California, Irvine. He completed a general surgery residency program at Harbor-UCLA Medical Center and was board certified in general surgery in 1997. Dr. Theuer’s previous research involved immunotoxin and cancer vaccine development, translational work in cancer patients, and gastrointestinal cancer epidemiology. He is married with two adult children and enjoys hiking, coaching basketball, and sculling.